Erschienen in:
01.08.2012 | Breast Oncology
Radiofrequency Ablation After Breast Lumpectomy Added to Extend Intraoperative Margins in the Treatment of Breast Cancer (ABLATE): A Single-institution Experience
verfasst von:
Aimee Mackey, MD, Sheldon Feldman, MD, Amiya Vaz, BA, Lara Durrant, BA, Christopher Seaton, BA, V. Suzanne Klimberg, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 8/2012
Einloggen, um Zugang zu erhalten
Abstract
Background
Breast-conserving surgery is often preferred to treat early-stage breast cancer. This method aims to minimize repeat excision and local recurrence rates. The ABLATE Registry expands this to multiple centers with a total accrual goal of 250. This video illustrates an intraoperative radiofrequency ablation (RFA) technique.
Methods
Sixteen women with a mean age of 65 years underwent RFA after lumpectomy. The RFA probe was deployed 1 cm circumferentially in the cavity and maintained at 100°C for 15 min. The ablation zone was monitored with color-flow ultrasound. Patients returned 2 weeks later to complete the Subjective Cosmetic Scale and the European Organisation for Research and Treatment of Cancer Body Image Scale.
Results
At a mean follow-up of 3.9 months, there were no local recurrences. Two-week cosmesis scores were excellent (n = 9) or good (n = 5).
Conclusions
Our initial experience is encouraging. Continued national accrual will permit evaluation of reduction in repeat excision and local recurrence rate, as well as potentially reduce requirements for adjuvant radiation.